Skip to content
Screener

Net margin at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-8.9%-20.5pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-4,612.1%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-529.2%-556pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
21.6%+8.9pp
Biogen logo
BiogenBIIB
8.8%-6.5pp

Other financials

Income statement

See full
Revenue--100%
Operating income-$96.9M-27.4%
Net income-$83.7M-17.7%
EPS (diluted)-$2.87+13.3%

Balance sheet

See full
Cash & equivalents$474.8M+201%
Total debt$1.1M+44.0%
Total equity$1.3B+232%
Total assets$1.4B+207%

Cash flow

See full
Operating cash flow-$77.5M-41.8%
CapEx$245.0K+338%
Free cash flow-$77.8M-42.1%

Valuation

See full
Market cap$8.9B+770%
Enterprise value$8.43B+873%

Profitability

See full
Operating margin-3,927.5%-1,497pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-38.9%-10.3pp
Debt / equity0.0×
Current ratio15.7×+9.4×

Where this comes from

Calculated from Praxis Precision Medicines, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed November 5, 2025. Open the filing →

Filed
Nov 5, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q3 2025
Accession
0001689548-25-000111

FAQ

What is Praxis Precision Medicines, Inc.'s net margin?
Praxis Precision Medicines, Inc. (PRAX) reported net margin of -3,658.5% in Q3 2025.
How has Praxis Precision Medicines, Inc.'s net margin changed year-over-year?
Praxis Precision Medicines, Inc.'s net margin increased by 61.1% year-over-year, from -9,409.2% to -3,658.5%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Praxis Precision Medicines, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude